Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells.
Journal: Molecular cancer research : MCR
Published: February 22, 2021
Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance.
Journal: Molecular cancer research : MCR
Published: January 17, 2020
The IncRNA BORG: A novel inducer of TNBC metastasis, chemoresistance, and disease recurrence.
Journal: Journal of cancer metastasis and treatment
Published: August 23, 2019
SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.
Journal: Life science alliance
Published: May 14, 2019
The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.
Journal: Oncogene
Published: July 25, 2018
Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells.
Journal: Translational cancer research
Published: July 07, 2017
The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.
Journal: Scientific reports
Published: June 20, 2017
Showing 1-7 of 7
Last Updated: 09/26/2026